Adknoma Health Research   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Madrid Spain (2004)

Organization Overview

First Clinical Trial
2012
NCT01529320
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Adknoma | Adknoma Health Research | Adknoma Health Research, S.L.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis, Contact (Phase 1)

Multiple Myeloma (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 13